Literature DB >> 26228483

Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.

Joni M Prasad1, Oleg V Gorkun2, Harini Raghu1, Sherry Thornton3, Eric S Mullins4, Joseph S Palumbo4, Ya-Ping Ko5, Magnus Höök5, Tovo David6, Shaun R Coughlin6, Jay L Degen1, Matthew J Flick1.   

Abstract

Fibrin(ogen) is central to hemostasis and thrombosis and also contributes to multiple physiologic and pathologic processes beyond coagulation. However, the precise contribution of soluble fibrinogen vs insoluble fibrin matrices to vascular integrity, tissue repair, inflammation, and disease has been undefined and unapproachable. To establish the means to distinguish fibrinogen- and fibrin-dependent processes in vivo, Fib(AEK) mice were generated that carry normal levels of circulating fibrinogen but lack the capacity for fibrin polymer formation due to a germ-line mutation in the Aα chain thrombin cleavage site. Homozygous Fib(AEK) mice developed to term and exhibited postnatal survival superior to that of fibrinogen-deficient mice. Unlike fibrinogen-deficient mice, platelet-rich plasma from Fib(AEK) mice supported normal platelet aggregation in vitro, highlighting that fibrinogen(AEK) retains the functional capacity to support interactions with platelets. Thrombin failed to release fibrinopeptide-A from fibrinogen(AEK) and failed to induce polymer formation with Fib(AEK) plasma or purified fibrinogen(AEK) in 37°C mixtures regardless of incubation time. Fib(AEK) mice displayed both an absence of fibrin polymer formation following liver injury, as assessed by electron microscopy, and a failure to generate stable occlusive thrombi following FeCl3 injury of carotid arteries. Fib(AEK) mice exhibited a profound impediment in Staphylococcus aureus clearance following intraperitoneal infection similar to fibrinogen-deficient mice, yet Fib(AEK) mice displayed a significant infection dose-dependent survival advantage over fibrinogen-deficient mice following peritonitis challenge. Collectively, these findings establish for the first time that fibrin polymer is the molecular form critical for antimicrobial mechanisms while simultaneously highlighting biologically meaningful contributions and functions of the soluble molecule.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26228483      PMCID: PMC4616238          DOI: 10.1182/blood-2015-04-639849

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  65 in total

1.  Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen.

Authors:  Joan A Geoghegan; Vannakambadi K Ganesh; Emanuel Smeds; Xiaowen Liang; Magnus Höök; Timothy J Foster
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

2.  Two-photon intravital imaging of thrombus development.

Authors:  Malgorzata M Kamocka; Jian Mu; Xiaomin Liu; Nan Chen; Amy Zollman; Barbara Sturonas-Brown; Kenneth Dunn; Zhiliang Xu; Danny Z Chen; Mark S Alber; Elliot D Rosen
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

4.  Inhibiting platelets aggregation could aggravate the acute infection caused by Staphylococcus aureus.

Authors:  Xin Zhang; Yu Liu; Yaping Gao; Jie Dong; Chunhua Mu; Qiang Lu; Ningsheng Shao; Guang Yang
Journal:  Platelets       Date:  2011-01-25       Impact factor: 3.862

5.  Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence.

Authors:  T Vanassche; J Verhaegen; W E Peetermans; J VAN Ryn; A Cheng; O Schneewind; M F Hoylaerts; P Verhamme
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

6.  Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition.

Authors:  L R Languino; A Duperray; K J Joganic; M Fornaro; G B Thornton; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction.

Authors:  Y Katagiri; T Hiroyama; N Akamatsu; H Suzuki; H Yamazaki; K Tanoue
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

8.  Contribution of coagulases towards Staphylococcus aureus disease and protective immunity.

Authors:  Alice G Cheng; Molly McAdow; Hwan K Kim; Taeok Bae; Dominique M Missiakas; Olaf Schneewind
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

9.  In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation.

Authors:  Peter Panizzi; Matthias Nahrendorf; Jose-Luiz Figueiredo; Jennifer Panizzi; Brett Marinelli; Yoshiko Iwamoto; Edmund Keliher; Ashoka A Maddur; Peter Waterman; Heather K Kroh; Florian Leuschner; Elena Aikawa; Filip K Swirski; Mikael J Pittet; Tilman M Hackeng; Pablo Fuentes-Prior; Olaf Schneewind; Paul E Bock; Ralph Weissleder
Journal:  Nat Med       Date:  2011-08-21       Impact factor: 53.440

10.  Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model.

Authors:  Christoph Guggenberger; Christiane Wolz; Julie A Morrissey; Jürgen Heesemann
Journal:  PLoS Pathog       Date:  2012-01-12       Impact factor: 6.823

View more
  38 in total

1.  Not fibrin(ogen), but fibrinogen or fibrin.

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

Review 2.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 3.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

4.  Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation.

Authors:  Lakmali Munasinghage Silva; Andrew Gary Lum; Collin Tran; Molly W Shaw; Zhen Gao; Matthew J Flick; Niki M Moutsopoulos; Thomas H Bugge; Eric S Mullins
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

5.  Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.

Authors:  L G Poole; A Pant; K S Baker; A K Kopec; H M Cline-Fedewa; S E Iismaa; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2018-12-10       Impact factor: 5.824

6.  Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability.

Authors:  Rami Abu-Fanne; Victoria Stepanova; Rustem I Litvinov; Suhair Abdeen; Khalil Bdeir; Mohamed Higazi; Emad Maraga; Chandrasekaran Nagaswami; Alexander R Mukhitov; John W Weisel; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

Review 7.  The multifaceted role of fibrinogen in tissue injury and inflammation.

Authors:  James P Luyendyk; Jonathan G Schoenecker; Matthew J Flick
Journal:  Blood       Date:  2018-12-06       Impact factor: 22.113

Review 8.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

9.  Structure, Mechanics, and Instability of Fibrin Clot Infected with Staphylococcus epidermidis.

Authors:  Tianhui Maria Ma; J Scott VanEpps; Michael J Solomon
Journal:  Biophys J       Date:  2017-11-07       Impact factor: 4.033

Review 10.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.